Daniel E. Ryweck is Chief Financial Officer of Silo Pharma, Inc.. Currently has a direct ownership of 5,000 shares of SILO, which is worth approximately $4,300. The most recent transaction as insider was on May 26, 2023, when has been sold 1,000 shares (Common Stock) at a price of $2.13 per share, resulting in proceeds of $2,130. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $4,300

Daniel E. Ryweck Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 26 2023
BUY
Open market or private purchase
$2,130 $2.13 p/Share
1,000 Added 16.67%
5,000 Common Stock
DER

Daniel E. Ryweck

Chief Financial Officer
Englewood Cliffs, NJ

Track Institutional and Insider Activities on SILO

Follow Silo Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SILO shares.

Notify only if

Insider Trading

Get notified when an Silo Pharma, Inc. insider buys or sells SILO shares.

Notify only if

News

Receive news related to Silo Pharma, Inc.

Track Activities on SILO